Determining the optimal size of small molecule mixtures for high throughput NMR screening
- PMID: 15803397
- DOI: 10.1007/s10858-005-0948-4
Determining the optimal size of small molecule mixtures for high throughput NMR screening
Abstract
High-throughput screening (HTS) using NMR spectroscopy has become a common component of the drug discovery effort and is widely used throughout the pharmaceutical industry. NMR provides additional information about the nature of small molecule-protein interactions compared to traditional HTS methods. In order to achieve comparable efficiency, small molecules are often screened as mixtures in NMR-based assays. Nevertheless, an analysis of the efficiency of mixtures and a corresponding determination of the optimum mixture size (OMS) that minimizes the amount of material and instrumentation time required for an NMR screen has been lacking. A model for calculating OMS based on the application of the hypergeometric distribution function to determine the probability of a "hit" for various mixture sizes and hit rates is presented. An alternative method for the deconvolution of large screening mixtures is also discussed. These methods have been applied in a high-throughput NMR screening assay using a small, directed library.
Similar articles
-
Design of small molecule libraries for NMR screening and other applications in drug discovery.Curr Top Med Chem. 2003;3(1):11-23. doi: 10.2174/1568026033392606. Curr Top Med Chem. 2003. PMID: 12570776 Review.
-
Use of (1)H NMR to facilitate solubility measurement for drug discovery compounds.Int J Pharm. 2009 Mar 18;369(1-2):47-52. doi: 10.1016/j.ijpharm.2008.10.038. Epub 2008 Nov 27. Int J Pharm. 2009. PMID: 19073245
-
NMR-based screening methods for lead discovery.EXS. 2003;(93):183-202. doi: 10.1007/978-3-0348-7997-2_9. EXS. 2003. PMID: 12613177 Review.
-
High-throughput nuclear magnetic resonance-based screening.J Med Chem. 1999 Jul 1;42(13):2315-7. doi: 10.1021/jm9901475. J Med Chem. 1999. PMID: 10395471
-
Application of NMR screening in drug discovery.Curr Top Med Chem. 2003;3(1):81-97. doi: 10.2174/1568026033392796. Curr Top Med Chem. 2003. PMID: 12570779 Review.
Cited by
-
Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?Front Mol Biosci. 2022 Feb 18;9:834453. doi: 10.3389/fmolb.2022.834453. eCollection 2022. Front Mol Biosci. 2022. PMID: 35252355 Free PMC article.
-
Multiplexing siRNAs to compress RNAi-based screen size in human cells.Nucleic Acids Res. 2007;35(8):e57. doi: 10.1093/nar/gkm141. Epub 2007 Mar 28. Nucleic Acids Res. 2007. PMID: 17392344 Free PMC article.
-
A multi-step NMR screen for the identification and evaluation of chemical leads for drug discovery.Comb Chem High Throughput Screen. 2009 Mar;12(3):285-95. doi: 10.2174/138620709787581738. Comb Chem High Throughput Screen. 2009. PMID: 19275534 Free PMC article.
-
The application of FAST-NMR for the identification of novel drug discovery targets.Drug Discov Today. 2008 Feb;13(3-4):172-9. doi: 10.1016/j.drudis.2007.11.001. Drug Discov Today. 2008. PMID: 18275915 Free PMC article. Review.
-
NMRmix: A Tool for the Optimization of Compound Mixtures in 1D (1)H NMR Ligand Affinity Screens.J Proteome Res. 2016 Apr 1;15(4):1360-8. doi: 10.1021/acs.jproteome.6b00121. Epub 2016 Mar 23. J Proteome Res. 2016. PMID: 26965640 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical